Financials Mercator Medical S.A.

Equities

MRC

PLMRCTR00015

Medical Equipment, Supplies & Distribution

Market Closed - Warsaw S.E. 11:55:56 2024-05-02 am EDT 5-day change 1st Jan Change
42.05 PLN -1.06% Intraday chart for Mercator Medical S.A. +0.36% +1.33%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 114.4 105.4 4,469 1,033 525.4 441.9
Enterprise Value (EV) 1 249.4 238.8 3,926 502.3 107 120.4
P/E ratio 15.3 x -45.2 x 4.78 x 2.2 x -2.54 x -17.4 x
Yield - 5.03% - - 5.07% -
Capitalization / Revenue 0.27 x 0.19 x 2.43 x 0.6 x 0.97 x 0.86 x
EV / Revenue 0.59 x 0.44 x 2.14 x 0.29 x 0.2 x 0.23 x
EV / EBITDA 8.96 x 10.2 x 3.69 x 1.04 x -2.11 x -1.85 x
EV / FCF -4.26 x 24.9 x 9.37 x 2.57 x -1.06 x -3.32 x
FCF Yield -23.5% 4.02% 10.7% 38.9% -93.9% -30.1%
Price to Book 0.86 x 0.79 x 4.22 x 0.9 x 0.52 x 0.21 x
Nbr of stocks (in thousands) 10,589 10,589 10,589 10,647 10,647 10,647
Reference price 2 10.80 9.950 422.0 97.00 49.35 41.50
Announcement Date 3/25/19 3/30/20 3/17/21 4/14/22 5/2/23 4/29/24
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 420.4 540.3 1,835 1,729 542.8 514.7
EBITDA 1 27.84 23.35 1,065 481.3 -50.74 -65
EBIT 1 14.19 6.982 1,047 463 -74.75 -87.12
Operating Margin 3.38% 1.29% 57.05% 26.77% -13.77% -16.93%
Earnings before Tax (EBT) 1 8.131 2.069 1,041 477.2 -186.2 -3.792
Net income 1 7.468 -2.328 930.2 446.9 -189.6 -19.68
Net margin 1.78% -0.43% 50.68% 25.84% -34.94% -3.82%
EPS 2 0.7053 -0.2200 88.33 44.15 -19.41 -2.380
Free Cash Flow 1 -58.55 9.599 418.7 195.4 -100.5 -36.26
FCF margin -13.93% 1.78% 22.82% 11.3% -18.52% -7.04%
FCF Conversion (EBITDA) - 41.11% 39.32% 40.6% - -
FCF Conversion (Net income) - - 45.02% 43.73% - -
Dividend per Share - 0.5000 - - 2.500 -
Announcement Date 3/25/19 3/30/20 3/17/21 4/14/22 5/2/23 4/29/24
1PLN in Million2PLN
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3
Net sales 1 - 168.5
EBITDA 1 - 8.012
EBIT 1 - 1.165
Operating Margin - 0.69%
Earnings before Tax (EBT) - -
Net income -11.12 -
Net margin - -
EPS -1.140 -
Dividend per Share - -
Announcement Date 9/30/22 11/29/22
1PLN in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 135 133 - - - -
Net Cash position 1 - - 543 530 418 321
Leverage (Debt/EBITDA) 4.851 x 5.717 x - - - -
Free Cash Flow 1 -58.6 9.6 419 195 -101 -36.3
ROE (net income / shareholders' equity) 5.57% -1.55% 159% 40.7% -17.7% -2.44%
ROA (Net income/ Total Assets) 2.64% 1.14% 78.1% 22.4% -3.94% -5.32%
Assets 1 282.6 -203.5 1,191 1,991 4,813 370.1
Book Value Per Share 2 12.50 12.60 99.90 107.0 94.70 202.0
Cash Flow per Share 2 1.530 1.400 38.40 31.90 21.00 51.00
Capex 1 43.1 15.6 15.5 177 110 39.1
Capex / Sales 10.24% 2.88% 0.84% 10.22% 20.2% 7.59%
Announcement Date 3/25/19 3/30/20 3/17/21 4/14/22 5/2/23 4/29/24
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRC Stock
  4. Financials Mercator Medical S.A.